|
KR20210014607A
|
|
Novel anticancer compound, and pharmaceutical comprising thereof as an active ingredient
|
|
WO2020111869A1
|
|
Pharmaceutical composition for co-administration of acidosis-inducing drug
|
|
WO2020111866A1
|
|
Pharmaceutical composition for prevention or treatment of acidosis
|
|
KR20200066213A
|
|
A pharmaceutical composition for co-administration with acidosis inducing agent
|
|
KR20210025822A
|
|
Method for manufacturing biguanide derivatives
|
|
KR20210022926A
|
|
A process for preparing [14C]gossypol as radiolabeled compound and intermediates useful for synthesis thereof
|
|
KR102088689B1
|
|
A pharmaceutical composition for prevention or treatment of acidosis
|
|
KR20210018564A
|
|
Method for mass-refining of plant-derived polyphenols
|
|
KR102011815B1
|
|
A pharmaceutical composition for prevention or treatment of acidosis
|
|
KR20180121771A
|
|
Pharmaceutical composition for preventing or treating cancer
|
|
KR20190128806A
|
|
Pharmaceutical composition for preventing or treating cancer
|
|
KR20180055423A
|
|
Pharmaceutical composition for preventing or treating cancer
|
